Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,880
Total Claims
$778K
Drug Cost
222
Beneficiaries
$3,504
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 16,767 Hospitalist providers
-75%
Opioid rate vs peers
0.8% vs 3.0% avg
+720%
Cost per patient vs peers
$3,504 vs $427 avg
+328%
Brand preference vs peers
22.4% vs 5.2% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Cost per patient is 720% above the specialty average. Extreme cost outliers may indicate prescribing of unnecessarily expensive brand-name drugs or inappropriate drug utilization.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.8%
Opioid Rate
67
Opioid Claims
$778
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,975 claims · $558K
Generic: 6,835 claims · $213K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 277 | $73K |
| Pimavanserin Tartrate | 26 | $58K |
| Liraglutide | 92 | $51K |
| Rifaximin | 27 | $44K |
| Sitagliptin Phosphate | 121 | $33K |
| Aripiprazole | 115 | $28K |
| Rivaroxaban | 72 | $21K |
| Insulin Aspart | 64 | $20K |
| Fluticasone/Vilanterol | 51 | $18K |
| Mirabegron | 90 | $18K |
| Dapagliflozin Propanediol | 62 | $17K |
| Lacosamide | 41 | $15K |
| Insulin Glargine,hum.Rec.Anlog | 100 | $13K |
| Insulin Glargine,hum.Rec.Anlog | 37 | $12K |
| Varicella-Zoster Ge/As01b/Pf | 55 | $11K |
Prescribing Profile
Patient Profile
75
Avg Age
59%
Female
2.21
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About